<scp>CYT</scp>003, a <scp>TLR</scp>9 agonist, in persistent allergic asthma – a randomized placebo‐controlled Phase 2b studyThomas B. Casale, M.E. Wechsler, Jeremy Cole et al.|Allergy|2015Cited by 68
Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal DiseaseStefan Scholz, Wolfgang Greiner, Melanie Schneider et al.|Infectious Diseases and Therapy|2021Cited by 19